| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Payments of retirement fees for redemption of high trail notes | 0 | - |
| Net cash provided by/(used in) financing activities | 22,436 | 12,360 |
| Effect of exchange rates on cash, cash equivalents and restricted cash | -18 | -33 |
| Net decrease in cash, cash equivalents and restricted cash | -6,508 | -6,011 |
| Cash and cash equivalents at beginning of period | 9,573 | - |
| Cash and cash equivalents at end of period | 3,065 | - |
Bionano Genomics, Inc. (BNGO)
Bionano Genomics, Inc. (BNGO)